Berger T - Search Results

1

Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.

Haschka D, Tymoszuk P, Bsteh G, Petzer V, Berek K, Theurl I, Berger T, Weiss G. Haschka D, et al. Among authors: berger t. Front Immunol. 2020 Apr 29;11:594. doi: 10.3389/fimmu.2020.00594. eCollection 2020. Front Immunol. 2020. PMID: 32411125 Free PMC article.

2

Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis.

Hilbe W, Berger T, Konwalinka G, Thaler J. Hilbe W, et al. Among authors: berger t. Acta Haematol. 1999;102(2):99-100. doi: 10.1159/000040978. Acta Haematol. 1999. PMID: 10529514

3

Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.

Schocke MF, Berger T, Felber SR, Wolf C, Deisenhammer F, Kremser C, Seppi K, Aichner FT. Schocke MF, et al. Among authors: berger t. Neuroimage. 2003 Oct;20(2):1253-63. doi: 10.1016/S1053-8119(03)00409-9. Neuroimage. 2003. PMID: 14568494 Clinical Trial.

4

Multiple sclerosis.

Berger T. Berger T. Autoimmunity. 2004 Jun;37(4):321-4. doi: 10.1080/08916930410001708742. Autoimmunity. 2004. PMID: 15518051 Free article. Review. No abstract available.

5

Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.

Kuenz B, Lutterotti A, Khalil M, Ehling R, Gneiss C, Deisenhammer F, Reindl M, Berger T. Kuenz B, et al. Among authors: berger t. J Neuroimmunol. 2005 Oct;167(1-2):143-9. doi: 10.1016/j.jneuroim.2005.06.019. J Neuroimmunol. 2005. PMID: 16040131

6

Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

Lutterotti A, Kuenz B, Gredler V, Khalil M, Ehling R, Gneiss C, Egg R, Deisenhammer F, Berger T, Reindl M. Lutterotti A, et al. Among authors: berger t. J Neuroimmunol. 2006 Dec;181(1-2):145-9. doi: 10.1016/j.jneuroim.2006.09.002. Epub 2006 Oct 13. J Neuroimmunol. 2006. PMID: 17046070

7

Biomarkers in multiple sclerosis: role of antibodies.

Berger T, Reindl M. Berger T, et al. Dis Markers. 2006;22(4):207-12. doi: 10.1155/2006/602103. Dis Markers. 2006. PMID: 17124342 Free PMC article. Review.

8

Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.

Gneiss C, Tripp P, Reichartseder F, Egg R, Ehling R, Lutterotti A, Khalil M, Kuenz B, Mayringer I, Reindl M, Berger T, Deisenhammer F. Gneiss C, et al. Among authors: berger t. Mult Scler. 2006 Dec;12(6):731-7. doi: 10.1177/1352458506070941. Mult Scler. 2006. PMID: 17263000

9

Multiple sclerosis: disease biomarkers as indicated by pathophysiology.

Berger T, Reindl M. Berger T, et al. J Neurol Sci. 2007 Aug 15;259(1-2):21-6. doi: 10.1016/j.jns.2006.05.070. Epub 2007 Mar 26. J Neurol Sci. 2007. PMID: 17367811 Review.

10

Biological markers for multiple sclerosis.

Lutterotti A, Berger T, Reindl M. Lutterotti A, et al. Among authors: berger t. Curr Med Chem. 2007;14(18):1956-65. doi: 10.2174/092986707781368478. Curr Med Chem. 2007. PMID: 17691938 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,072 results

Search Page